v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 100,889 $ 106,447
General and administrative 24,387 15,925
Total operating expenses 125,276 122,372
Loss from operations (125,276) (122,372)
Other income (expense):    
Interest income 8,757 7,100
Interest expense (4,202) 0
Other income (expense), net (133) (89)
Total other income (expense), net 4,422 7,011
Net loss $ (120,854) $ (115,361)
Net loss per share - basic $ (0.73) $ (1.05)
Net loss per share - diluted $ (0.73) $ (1.05)
Weighted average common shares outstanding, basic 165,036,604 109,911,628
Weighted average common shares outstanding, diluted 165,036,604 109,911,628
Comprehensive loss:    
Net Income (Loss) $ (120,854) $ (115,361)
Other comprehensive loss:    
Unrealized gains on marketable securities, net (612) 235
Comprehensive loss $ (121,466) $ (115,126)